Volume 16, Number 3 (May/Jun 2025)
In the online first section, learn about tools for managing indolent systemic mastocytosis and systemic mastocytosis. Read about an APRN-led intervention for supporting patients as they transition from completing a phase I clinical trial. Using data from a Texas cancer screening program, the article by Chen and colleagues examined the impact of geographical factors, specifically rurality, persistent poverty, and racial residential segregation, on colorectal cancer screening adherence. In this issue’s review article, get pharmacist perspectives and strategies for talquetamab for relapsed/refractory multiple myeloma. A case report in this issue highlights a patient who developed progressive multifocal leukoencephalopathy just 2 months after CAR T-cell therapy and underscores the need for better prevention and treatment strategies in immunocompromised patients.
In this issue, a case describes a 10-year discordance of imaging that proved to be high-grade ductal carcinoma in situ, and therefore emphasizes the importance of understanding imaging protocols, recognizing imaging discrepancies, and guiding follow-up imaging procedures. A pilot program researched a walking plan and nurse education program to address cancer-related fatigue in patients undergoing cancer treatment.
